Cumberland Pharmaceuticals price to free cash flow CPIX

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 186×
10-year median: 9.5×
Against its 10-year history: 94th; percentile: 0 is its lowest day, 100 its highest
10-year range: 2.3× to 253×
Peer median: 11.4×

Cumberland Pharmaceuticals' price to free cash flow is 186× as of Oct 23, 2026.

That is above its ten-year median of 9.5×, higher than on 94% of days in the last ten years.

Over that time it ranged from 2.3× in Sep 2023 to 253× in Mar 2017.

The median for 10 large drugmakers of a similar size is 11.4×.

Price to free cash flow over time

median 9.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	186×	7.8×	186×
2025	9.2×	4.4×	16.3×
2024	3.9×	3.3×	4.4×
2023	3.0×	2.3×	6.1×
2022	5.0×	4.7×	12.4×
2021	13.6×	6.5×	14.9×
2020	8.5×	8.5×	21.6×
2019	14.3×	13.2×	48.0×
2018	77.3×	63.8×	217×
2017	225×	85.2×	253×
2016	95.8×	10.5×	97.4×
2015	12.1×	10.5×	33.4×
2014	28.9×	24.0×	130×
2013	35.1×	13.2×	35.1×
2012	13.4×	11.8×	18.9×

Against its peers

Companies in Drug Manufacturers - General nearest Cumberland Pharmaceuticals' size, closest first, today.

Company	Price to free cash flow
CPIXCumberland Pharmaceuticals	186×
NATRNatures Sunshine Products	11.8×
LFVNLifevantage	11.0×
SPROSpero Therapeutics	n/m
ATNMActinium Pharmaceuticals	n/m
ARVNArvinas	n/m
PBYIPuma Biotechnology	13.8×
IRWDIronwood Pharmaceuticals	n/m
ZVRAZevra Therapeutics	17.9×
CRMDCorMedix	2.4×
COLLCollegium Pharmaceutical	2.3×
Peer median	11.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Cumberland Pharmaceuticals

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.